Company intelligence / Profile preview

Pyrus Medical

San Jose, California, USA

Ownership: Private
Development stage: Other

Overview

Pyrus Medical was a medical technology company dedicated to improving vascular access for patients requiring hemodialysis. The company developed the WavelinQ EndoAVF System, a first-of-its-kind catheter-based technology that allows for the creation of arteriovenous fistulas (AVF) using a minimally invasive approach. This procedure provides an alternative to traditional open surgery, potentially reducing vessel trauma and improving the efficiency of dialysis access. Pyrus Medical's innovation addressed a significant unmet need in the management of end-stage renal disease. The company was acquired by C. R. Bard in 2017, and its technology is now part of the BD (Becton, Dickinson and Company) peripheral intervention portfolio.

Therapeutic areas: CardiovascularNephrology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Pyrus Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyrus Medical.

Explore the full profile